Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Potti

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Nursing Practice|March 15, 2006
Ineffectiveness of the measurement of 'routine' vital signs for adult inpatients with community-acquired pneumoniaPaul Mariani, Musab U Saeed, Anil Potti, et al.
American Journal of Clinical Oncology|February 2, 2002
Late adrenal metastasis in operable non-small-cell lung carcinomaMajdi M Abdel-Raheem, Anil Potti, William K Becker, et al.
American Journal of Clinical Oncology|April 26, 2003
HER-2/neu overexpression detected by immunohistochemistry in soft tissue sarcomasHeidi Foster, Stacey Knox, Apar Kishor Ganti, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion. A new variant?Anil Potti, Amit Panwalkar, Mark C Ingebretson, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinomaAnil Potti, James Willardson, Caralee Forseen, et al.
Cancer Investigation|November 30, 2004
Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumorsAnil Potti, Scott E Forseen, Vijay K Koka, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potentialEran R Andrechek, Robert D Cardiff, Jeffrey T Chang, et al.
Cancer Research|October 17, 2008
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphomaSeiichi Mori, Rachel E Rempel, Jeffrey T Chang, et al.
Anticancer Research|March 16, 2004
Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomasAnil Potti, Apar Kishor Ganti, Heidi Foster, et al.
JAMA|February 11, 2010
Age- and sex-specific genomic profiles in non-small cell lung cancerWilliam Mostertz, Marvaretta Stevenson, Chaitanya Acharya, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Nursing Practice|March 15, 2006
Ineffectiveness of the measurement of 'routine' vital signs for adult inpatients with community-acquired pneumoniaPaul Mariani, Musab U Saeed, Anil Potti, et al.
American Journal of Clinical Oncology|February 2, 2002
Late adrenal metastasis in operable non-small-cell lung carcinomaMajdi M Abdel-Raheem, Anil Potti, William K Becker, et al.
American Journal of Clinical Oncology|April 26, 2003
HER-2/neu overexpression detected by immunohistochemistry in soft tissue sarcomasHeidi Foster, Stacey Knox, Apar Kishor Ganti, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion. A new variant?Anil Potti, Amit Panwalkar, Mark C Ingebretson, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinomaAnil Potti, James Willardson, Caralee Forseen, et al.
Cancer Investigation|November 30, 2004
Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumorsAnil Potti, Scott E Forseen, Vijay K Koka, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potentialEran R Andrechek, Robert D Cardiff, Jeffrey T Chang, et al.
Cancer Research|October 17, 2008
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphomaSeiichi Mori, Rachel E Rempel, Jeffrey T Chang, et al.
Anticancer Research|March 16, 2004
Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomasAnil Potti, Apar Kishor Ganti, Heidi Foster, et al.
JAMA|February 11, 2010
Age- and sex-specific genomic profiles in non-small cell lung cancerWilliam Mostertz, Marvaretta Stevenson, Chaitanya Acharya, et al.
Pageof 10